# Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism

> **NCT00307840** · PHASE4 · COMPLETED · sponsor: **Papageorgiou General Hospital**

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** paricalcitol

## Key facts

- **NCT ID:** NCT00307840
- **Lead sponsor:** Papageorgiou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307840, "Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00307840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*